HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Giuseppe Pelosi Selected Research

Large Cell Carcinoma

6/2013ΔNp63 (p40) distribution inside lung cancer: a driver biomarker approach to tumor characterization.
11/2011Heterogeneity of large cell carcinoma of the lung: an immunophenotypic and miRNA-based analysis.
5/2009Desmocollin-3: a new marker of squamous differentiation in undifferentiated large-cell carcinoma of the lung.
4/2008Genetic alterations in combined neuroendocrine neoplasms of the lung.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Giuseppe Pelosi Research Topics

Disease

89Neoplasms (Cancer)
01/2022 - 05/2002
35Carcinoma (Carcinomatosis)
10/2021 - 05/2002
29Lung Neoplasms (Lung Cancer)
01/2021 - 11/2003
22Carcinoid Tumor (Carcinoid)
10/2021 - 11/2003
19Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2018 - 11/2003
14Neuroendocrine Tumors (Neuroendocrine Tumor)
03/2021 - 03/2005
11Adenocarcinoma
07/2021 - 01/2006
11Small Cell Carcinoma
01/2020 - 11/2003
10Breast Neoplasms (Breast Cancer)
01/2022 - 06/2003
9Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2017 - 01/2006
5Adenocarcinoma of Lung
12/2021 - 12/2013
5Adenosquamous Carcinoma
10/2021 - 06/2011
5Colorectal Neoplasms (Colorectal Cancer)
10/2018 - 03/2008
5Neoplasm Metastasis (Metastasis)
11/2017 - 09/2005
5Small Cell Lung Carcinoma (Small Cell Lung Cancer)
04/2011 - 05/2002
4Neuroendocrine Carcinoma
03/2021 - 12/2005
4Mesothelioma
01/2017 - 06/2010
4Large Cell Carcinoma
06/2013 - 04/2008
3Prostatic Neoplasms (Prostate Cancer)
11/2019 - 05/2007
3Hyperplasia
11/2019 - 08/2011
3Disease Progression
04/2016 - 05/2007
3Melanoma (Melanoma, Malignant)
01/2015 - 02/2012
3Carcinosarcoma
06/2013 - 04/2012
3Sarcoma (Soft Tissue Sarcoma)
04/2011 - 05/2004
3Lymphatic Metastasis
03/2006 - 11/2003
2Idiopathic Pulmonary Fibrosis
06/2022 - 03/2010
2Retinoblastoma (Glioblastoma, Retinal)
01/2019 - 07/2017
2Inflammation (Inflammations)
01/2018 - 03/2010
2Mucinous Adenocarcinoma (Mucinous Carcinoma)
04/2017 - 08/2014
2Necrosis
03/2017 - 06/2014
2Pulmonary Blastoma
09/2012 - 04/2012
2Endodermal Sinus Tumor (Endodermal Sinus Tumors)
06/2011 - 07/2006

Drug/Important Bio-Agent (IBA)

17Biomarkers (Surrogate Marker)IBA
01/2022 - 06/2003
14Biological ProductsIBA
10/2021 - 08/2008
11Proteins (Proteins, Gene)FDA Link
01/2019 - 11/2003
8Ki-67 Antigen (Ki 67 Antigen)IBA
01/2022 - 09/2003
7Messenger RNA (mRNA)IBA
11/2021 - 01/2006
7DNA (Deoxyribonucleic Acid)IBA
01/2019 - 11/2003
7VimentinIBA
07/2017 - 09/2003
6SynaptophysinIBA
10/2021 - 05/2003
6ErbB Receptors (EGF Receptor)IBA
12/2013 - 12/2004
6TamoxifenFDA LinkGeneric
11/2009 - 06/2003
6fascinIBA
04/2007 - 05/2003
5Chromogranin AIBA
04/2017 - 05/2003
5Protein Isoforms (Isoforms)IBA
11/2013 - 07/2006
4Thyroid Nuclear Factor 1IBA
01/2019 - 06/2011
4MucinsIBA
01/2018 - 05/2009
4Hematoxylin (Haematoxylon)IBA
10/2017 - 02/2005
4Eosine Yellowish-(YS) (Eosin)IBA
10/2017 - 02/2005
4Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2016 - 05/2007
4AsbestosIBA
01/2016 - 01/2006
4Gefitinib (Iressa)FDA Link
12/2013 - 02/2005
3CateninsIBA
10/2021 - 04/2016
3Coloring Agents (Dyes)IBA
10/2017 - 05/2009
3Keratin-7 (Cytokeratin 7)IBA
04/2017 - 06/2009
3Gonadal Steroid Hormones (Sex Hormones)IBA
04/2017 - 07/2006
3ChromatinIBA
01/2017 - 02/2005
3Cadherins (E-Cadherin)IBA
04/2016 - 11/2003
3MicroRNAs (MicroRNA)IBA
10/2015 - 08/2011
3Erlotinib Hydrochloride (CP 358,774)FDA Link
02/2015 - 11/2006
3ParaffinIBA
06/2014 - 04/2008
3Insulin-Like Growth Factor I (IGF-1)IBA
08/2009 - 06/2003
3Hormones (Hormone)IBA
05/2007 - 05/2003
2Antineoplastic Agents (Antineoplastics)IBA
01/2022 - 01/2016
2Histones (Histone)IBA
03/2021 - 01/2017
2B7-H1 AntigenIBA
01/2021 - 01/2020
2xylometazoline (stas)IBA
01/2020 - 11/2019
2Anaplastic Lymphoma KinaseIBA
11/2019 - 09/2012
2Circulating MicroRNAIBA
10/2019 - 10/2015
2ChromograninsIBA
01/2019 - 04/2011
2GemcitabineFDA Link
03/2018 - 04/2011
2Oncogene Proteins (Oncogene Protein)IBA
11/2017 - 01/2016
2Nuclear Proteins (Protein, Nuclear)IBA
11/2017 - 04/2017
2Cyclin D1IBA
07/2017 - 12/2005
2Colloids (Colloid)IBA
04/2017 - 08/2014
2Progesterone Receptors (Progesterone Receptor)IBA
04/2017 - 05/2002
2PlasticsIBA
12/2016 - 06/2007
2Alkaline PhosphataseIBA
04/2016 - 07/2006
2Cisplatin (Platino)FDA LinkGeneric
04/2016 - 05/2010
2Phosphotransferases (Kinase)IBA
04/2015 - 05/2008
2Monoclonal AntibodiesIBA
01/2015 - 11/2003
2LigandsIBA
01/2015 - 08/2008
2AntibodiesIBA
08/2014 - 12/2010
2Tyrosine Kinase InhibitorsIBA
04/2014 - 11/2006
2Cetuximab (Erbitux)FDA Link
01/2014 - 03/2008
2Imatinib Mesylate (Gleevec)FDA Link
08/2013 - 08/2008
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
02/2012 - 06/2004
2DesmocollinsIBA
11/2011 - 05/2009

Therapy/Procedure

26Therapeutics
01/2022 - 05/2002
14Drug Therapy (Chemotherapy)
01/2022 - 05/2002
5Immunotherapy
12/2021 - 01/2015
4Neoadjuvant Therapy
01/2020 - 11/2004
3Induction Chemotherapy
11/2017 - 12/2004
3Radiotherapy
11/2017 - 05/2002
3Adjuvant Chemotherapy
04/2016 - 11/2006
3Lymph Node Excision (Lymph Node Dissection)
04/2011 - 03/2006
3Pneumonectomy (Lung Volume Reduction)
03/2010 - 01/2005
2Chemoprevention
11/2019 - 11/2003
2Lasers (Laser)
03/2018 - 05/2014
2Precision Medicine
01/2018 - 06/2014